DealBeeline Medicines, a Boston-based autoimmune and inflammatory therapeutics developer, raised $426.3 million in a Series A fundraising round led by Bain Capital with participation from Canada Pension Plan Investment Board CPP Investments and Bristol Myers Squibb.
More on VCNewsDaily →
SERIES A
07/10/2026
Doctorsa, a Milan-based telemedicine platform for travellers, raised €1...
HTG Medical, a Prague-based automated ICU urine monitoring medtech, raised...
Avere Therapeutics, Inc., a San Francisco-based immunology drug developer,...
Swing Therapeutics, a San Francisco-based digital therapeutics company,...
AtaiBeckley Inc., a New York-based psychedelic therapeutics developer, was...
SONATA, a US-based physician-led preventive care platform, raised $7...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
